Anne-Marie de Groot
No más puestos en curso
Perfil
Anne-Marie de Groot worked as the Head of Clinical Supply Chain Strategic Management at Janssen Pharmaceuticals, Inc. from 2016 to 2019.
She also served as the Chief Ethics & Compliance Officer at Pharming Group NV from 2020 to 2021.
Prior to her professional experience, she obtained an undergraduate degree from Stichting Hogeschool Leiden.
Antiguos cargos conocidos de Anne-Marie de Groot.
Empresas | Cargo | Fin |
---|---|---|
PHARMING GROUP N.V. | Oficial de Cumplimiento | 01/05/2021 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01/01/2019 |
Formación de Anne-Marie de Groot.
Stichting Hogeschool Leiden | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PHARMING GROUP N.V. | Health Technology |
Empresas privadas | 1 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Anne-Marie de Groot